Aquaculture Vaccines Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2019 and Forecast 2020-2026

$ PRICE - $ 3,000.00$ 8,900.00

Aquaculture Vaccines Market By vaccine Type (Inactivated Vaccine, Attenuated Live Vaccine, DNA Vaccine, and Others), By Application (Bacterial Infection, Viral Infection, Combined Bacterial and Viral Infections, and Others), By Route of Administration (Immersion Vaccines, Injection Vaccines, and Oral Vaccines), By Species (Salmon, Seabass and Seabream, Tilapia, Trout, Turbot, and Carp), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Description

Global Aquaculture Vaccines Market:

The global aquaculture vaccines market accounted for US 371.8 Mn in 2019 and is expected to burgeon at 9.4% CAGR over the forecast years owing to increase in R&D for the innovative vaccines by the market players. For instance, in February 2018, In April 2016, Pharmaq and Zoetis introduced an innovative vaccine ALPHA JECT LiVac SRS that helps control Salmon Rickettsial Septicaemia (SRS) Syndrome. Moreover, increase in the production of aquaculture species in Norway, Chile, and USA, rise in demand for quality meat products, government support for the aquaculture farming, and increase in the prevalence of various aquaculture diseases are anticipated to propel the market over the forecast timeframe. For instance, in October 2017, approximately 125,000 salmon have died due to a disease outbreak at two fish farms on the Isle of Lewis due to bacterium Pasturella Skyensis infection. However, stringent regulations for the approval, limited number of existed vaccines, and complexity in the storage of vaccines are hamper the revenue of aquaculture vaccines market.

 

Increase in Prevalence of Aquaculture Diseases Enhance the Revenue of Aquaculture Vaccines Market

Increase in the prevalence of various aquaculture diseases is a key factor surge the growth of revenue of market over the forecast years. Water contamination due to residential and industrial wastage enhance the risk for aquaculture diseases which leads to surge in the adoption of vaccines by the famers. For instance, KV3 vaccine administration is increasing in China for carp species due to rise in Koi Herpes virus Disease, a viral disease of common carp Cyprinus carpio, including all its ornamental varieties such as koi, ghost koi etc. In addition, use of antibiotics in certain countries may enhance the adoption of vaccine over the forecast years. For instance, in 2017, The Marine Products Export Development Authority (MPEDA) has released a list of 20 antibiotics and pharmacologically active substances banned for use in aquaculture in India.

 

Europe Dominated the Global Market

In 2019, Europe dominated the global aquaculture vaccines market followed by Latin America and Asia Pacific. Europe alone contributed the more than 50% of global revenue share and the same trend is expected over the forecast years. The growth in this region can be attributed to rapid growth in Salmon production in Norway. For instance, in 2017, Norway alone produced about 48.0% salmon species among all the global production. Presence of huge number of vaccines for salmonid species enhance the revenue of market. However, in China, the production of carp, seabass and seabream, and tilapia production is gradually increasing which may leads to adoption of vaccines in the country. Moreover, international trading of aquaculture species between the countries also surge the adoption of vaccines over the forecast timeframe

 

Competition Assessment

Key player’s profiles in the global market include:

  • Pharmaq AS
  • Merck Animal Health
  • KoVax
  • Hipra
  • Tecnovax SA
  • Veterquimica S.A.
  • Nisseiken Co., Ltd.
  • Virbac

Global aquaculture vaccines market is escalating owing to strategic alliances by key players for aquaculture vaccines to meet the demands of the customers in the market. For instance,

  • In May 2019, Hipra launched ICTHIOVAC VNN, an injectable vaccine against Nodavirus for sea bass in the Mediterranean region
  • In December 2017, Merck Animal Health acquired Prondil S.A. for the expansion of vaccine portfolio and manufacturing capabilities

 

Global Aquaculture Vaccines Market Report Description:

Global aquaculture vaccines market report gives comprehensive outlook on aquaculture vaccines across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of vaccine type, application, route of administration, species type, and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global aquaculture vaccines products.

 

Key Findings of the Report:

  • Global aquaculture vaccines market expanding at significant CAGR over 2019 to 2026 due to increase in prevalence of aquaculture diseases
  • Based on region, Europe accounted for considerable market revenue share in 2019 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global market

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2014-2019) and forecast (2019-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Detailed Segmentation

 

Vaccine Type

  • Inactivated Vaccine
  • Attenuated Live Vaccine
  • DNA Vaccine
  • Others

Application

  • Bacterial Infection
  • Viral Infection
  • Combined Bacterial and Viral Infections
  • Others

Route of Administration

  • Immersion Vaccines
  • Injection Vaccines
  • Oral Vaccines

Species

  • Salmon
  • Seabass and Seabream
  • Tilapia
  • Trout
  • Turbot
  • Carp

By Geography

North America

  • USA
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • Au & NZ
  • Rest of Europe

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of MEA


Location

GEOGRAPHY

PBI Location Map

Competition Assessment

Key player’s profiles in the global aquaculture vaccines market include:

  • Pharmaq AS
  • Merck Animal Health
  • KoVax
  • Hipra
  • Tecnovax SA
  • Veterquimica S.A.
  • Nisseiken Co., Ltd.
  • Virbac

Ask An Analyst

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX